Life Sciences/Biotech

Health-Technology Forum April 10 In Midland

MIDLAND - The MidMichigan Innovation Center and BlueWater Angels along with the Office for Innovation at Covenant HealthCare will be co-hosting a health technology forum April 10 to showcase five new Michigan companies - each company having potential to dramatically impact the future of medicine. One of the roles of the Covenant HealthCare Office for

By |2013-04-05T00:00:00-04:00April 5th, 2013|Archive, Life Sciences/Biotech|

Investing In Healthcare: Opportunities From A Venture Capital Perspective

ANN ARBOR ? The next BioArbor on April 10 will feature two seasoned venture capital investors, both with capital to invest and novel investment strategies. Both are based outside of Michigan, yet have made local investments and are actively seeking opportunities to invest in Michigan. The event will offer a great platform to hear about

By |2013-04-03T00:00:00-04:00April 3rd, 2013|Archive, Life Sciences/Biotech|

Michigan Biotechnology Institute, MSU Ink Deal To Develop Bio-Based Tech

LANSING - The Michigan Biotechnology Institute and Michigan State University have entered into a new collaborative arrangement, under which promising bio-based technologies will be accelerated from the laboratory to commercial deployment. The agreement combines MSU?s research expertise with MBI?s ?derisking? process and advanced bioprocessing to quickly and efficiently demonstrate the market-readiness of new technologies. Intellectual

By |2013-03-22T00:00:00-04:00March 22nd, 2013|Archive, Life Sciences/Biotech|

National Federation Independent Business-Michigan Opposes Medicaid Expansion

LANSING - Some two-thirds of National Federation of Independent Business-Michigan members do not want to see the state expand Medicaid eligibility, the group announced Thursday. Small business owners feared the plan would end up costing the state in the end, NFIB State Director Charlie Owens said. "The governor and his team deserve credit for trying

By |2013-03-14T00:00:00-04:00March 14th, 2013|Archive, Life Sciences/Biotech|

Dominick Colangelo Named CEO Of Aastrom Biosciences

ANN ARBOR - Aastrom Biosciences Inc. announced Wednesday that it has named Dominick Colangelo president and CEO. Dan Orlando, who had been interim CEO of Aastrom since November, will continue as chief commercial officer. Orlando replaced had replaced Tim Mayleben. Colangelo has more than 20 years of experience in the pharmaceutical industry, including almost 10

By |2013-03-07T00:00:00-05:00March 7th, 2013|Archive, Life Sciences/Biotech|

GOP Splits As House OKs Federal-State Exchange Partnership

LANSING - Michigan House Republicans were nearly evenly divided on Thursday over legislation allocating federal funding for a federal-state partnership on the federally mandated health insurance exchange under the Patient Protection and Affordable Care Act, but the legislation still passed by a comfortable margin. HB 4111 was passed by the House on a 78-31 vote,

By |2013-03-01T00:00:00-05:00March 1st, 2013|Archive, Life Sciences/Biotech|

Michigan House Committee OKs Money For Federal-State Partnership On Exchange

LANSING - The Michigan House Appropriations Committee took the first step in setting up a federally mandated health insurance exchange under the Affordable Care Act on Wednesday when it approved appropriating federal funds for a federal-state partnership. The committee voted 24-3 to report HB 4111 , which would accept $30.67 million in federal grant money

By |2013-02-27T00:00:00-05:00February 27th, 2013|Archive, Life Sciences/Biotech|

Medical Devices Makes Could Provide Cure For Dubai’s ailments?

GRAND RAPIDS - As local medical device companies look for new growth opportunities, they may do well to consider serving the burgeoning market in the Middle East, specifically Dubai. That?s the word from Don Beery, director of the two-dozen-member West Michigan Medical Device Consortium, who attended Arab Health 2013 in Dubai in late January. Beery

By |2013-02-21T00:00:00-05:00February 21st, 2013|Archive, Life Sciences/Biotech|